1969
DOI: 10.1007/bf01901433
|View full text |Cite
|
Sign up to set email alerts
|

2,6-Dichlorobenzylidene amino guanidine acetate (Wy-8678). A new hypotensive agent

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
19
0

Year Published

1973
1973
1987
1987

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 32 publications
(21 citation statements)
references
References 0 publications
2
19
0
Order By: Relevance
“…The view that guanfacine and guanabenz are potent a2-adrenoceptor agonists is in agreement with other published observations, where these drugs as well as clonidine have been demonstrated to decrease the magnitude of the responses to sympathetic nerve stimu lation in several organs (2,(18)(19)(20). Moreover, guanfacine and guanabenz have been reported to decrease 3H-norepinephrine overflow in response to postganglionic sympathetic nerve stimulation in isolated mouse atria (18), rat cortex slices (18) and isolated rabbit heart (19, 20).…”
Section: Resultssupporting
confidence: 91%
See 1 more Smart Citation
“…The view that guanfacine and guanabenz are potent a2-adrenoceptor agonists is in agreement with other published observations, where these drugs as well as clonidine have been demonstrated to decrease the magnitude of the responses to sympathetic nerve stimu lation in several organs (2,(18)(19)(20). Moreover, guanfacine and guanabenz have been reported to decrease 3H-norepinephrine overflow in response to postganglionic sympathetic nerve stimulation in isolated mouse atria (18), rat cortex slices (18) and isolated rabbit heart (19, 20).…”
Section: Resultssupporting
confidence: 91%
“…Guanabenz and guanfacine are newly introduced antihypertensive drugs possessing a guanidine residue in their structural formula (1)(2)(3)(4)(5). In order to elucidate the mechanisms of action, many experiments have been carried out in a number of animals under various conditions.…”
mentioning
confidence: 99%
“…The magnitude of the rise elicited by these i3-blocking agents and the minimum doses of these agents required to cause the pressor action appeared to be related to their E3-blocking activities in the heart such as was also reported by several investigators (24)(25)(26)(27). Therefore, the magnitude of the rise and the minimum dose of these agents could be used to compare the relative ( blocking activity of these agents.…”
Section: Discussionsupporting
confidence: 55%
“…As shown in the lower right part in Fig. 1 (1,2,(8)(9)(10) and are also in part, approx. 1/3, attributed to inhibitory actions on peripheral adrenergic transmission such as a presynaptic a-receptor stimulating action for both agents and an additional guan ethidine-like neuron blocking action for guanabenz (3, 6).…”
mentioning
confidence: 73%